Topical Ruxolitinib Lichen Planus

Status Completed

Clinical Trial Summary

To evaluate the safety and efficacy of INCB018424 PHOSPHATE CREAM in cutaneous LP as assessed by the change in Physician Global Assessment (PGA), Body Surface Area (BSA), Index Treatment and Control Lesion by Clinical Assessment Scale of Severity for Index Lesion Signs and Symptoms (CAILS) score, Pruritus Numerical Rating Scale (NRS), and Skindex-16. To predict responses through the identification of unique biomarkers of LP at week 0 and utilizing RNA sequencing on responsive and non-responsive tissue at week 4.

Clinical Trial Description

This is a single center, exploratory, open-label, single-arm design study of 12 patients. Treatment naïve and treatment refractory patients with LP will be treated with INCB018424 PHOSPHATE CREAM. Patients who are non-responders, to physician choice standard of care, will undergo a washout period and will be enrolled in the study. The study consists of 3 epochs: screening/washout period (of at least 1 week and up to 4 weeks), treatment epoch (of 8 weeks from screen/washout), and follow up epoch (of 4 weeks). The screening and washout period will allow for treatment naïve/ new diagnosis LP to undergo evaluation and diagnosis and for treatment refractory to undergo a washout. The total duration of the study will be 13-16 weeks. ;

Study Design

Related Conditions & MeSH terms

Lichen Planus

Clinical Trial Details

NCT number	NCT03697460
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Completed
Phase	Phase 2
Start date	August 30, 2018
Completion date	August 25, 2020

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06021405` - Koebner's Phenomenon in Psoriasis and Lichen Planus	N/A
Recruiting	`NCT03340155` - Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases	N/A
Completed	`NCT05787925` - Adjunctive Oral Systemic Vitamin E Therapy on Salivary Nitric Oxide Level in Patients With Erosive Oral Lichen Planus	N/A
Completed	`NCT03630198` - Pain Outcomes Following Intralesional Corticosteroid Injections	Phase 4
Completed	`NCT04952961` - Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study	N/A
Recruiting	`NCT04697563` - Laser Therapy in Women With Lichenoid Disorders	N/A
Completed	`NCT03265093` - Use of Injectable Platelet Rich Fibrin in Lichen Planus	N/A
Completed	`NCT03858634` - A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases	Phase 2
Completed	`NCT02761122` - Implication of Human Papillomavirus (HPV) in Lichen Physiopathology in Human (HPVLichen)	N/A
Active, not recruiting	`NCT00691106` - A Multi-center Study to Evaluate the Safety of Etanercept in the Treatment of Lichen Planus	Phase 2
Terminated	`NCT05761158` - Study of the Characteristics of Pruritus in Patients With Frontal Fibrosing Alopecia or Lichen Planus Pilaris
Recruiting	`NCT02261662` - Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection	N/A
Not yet recruiting	`NCT04892381` - Assessment of PD-1 and PD-L1Tissue Expression Levels in Lichen Planus Patients: A Case-Control Study
Completed	`NCT05396261` - a Flexible Wound Dressing for the Management of Genital Skin Conditions	N/A
Recruiting	`NCT02532166` - Incidence of Esophageal Lichen Planus in Patients With Known Oral Lichen Planus	N/A
Recruiting	`NCT06327620` - Treatment Of Oral Lichen Planus	N/A
Completed	`NCT03796806` - Methods Validation Assessment for Study of Inflammatory Skin Disease
Completed	`NCT02850601` - Dexamethasone Solution for the Treatment of Oral Lichen Planus	Phase 2
Not yet recruiting	`NCT01041625` - Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus	Phase 2
Completed	`NCT00824889` - Exploratory Study of Natural Killer Cells in Human Skin	N/A